This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Kayoko Matsuzawa: Innovator in Pharmaceutical Chemistry
Introduction
Kayoko Matsuzawa is a prominent inventor based in Ageo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. Her work has led to advancements in bronchodilator medications, which are crucial for treating respiratory conditions.
Latest Patents
Matsuzawa holds a patent for "Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof." This patent describes novel pyrazolopyridylpyridazinone derivatives characterized by a general formula that includes pharmacologically acceptable salts. These compounds exhibit phosphodiesterase inhibiting activity and demonstrate a selective potent bronchodilating effect on the respiratory tract. The patent outlines a process for preparing these derivatives and highlights their potential use as active ingredients in bronchodilators.
Career Highlights
Matsuzawa is associated with Kyorin Pharmaceutical Co., Ltd., where she has been instrumental in research and development. Her innovative approach to drug formulation has garnered attention in the pharmaceutical industry. With her expertise, she has contributed to the advancement of treatments for respiratory diseases.
Collaborations
Matsuzawa has collaborated with notable colleagues, including Yasushi Kouno and Katsuya Awano. These partnerships have fostered a collaborative environment that enhances the research and development process within her organization.
Conclusion
Kayoko Matsuzawa's contributions to pharmaceutical chemistry, particularly through her patented innovations, underscore her role as a leading inventor in the field. Her work continues to impact the development of effective treatments for respiratory conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
